<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33515491</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>397</Volume><Issue>10273</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.</ArticleTitle><Pagination><StartPage>452</StartPage><EndPage>455</EndPage><MedlinePgn>452-455</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(21)00183-5</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(21)00183-5</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sabino</LastName><ForeName>Ester C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Departamento de Molestias Infecciosas e Parasitarias and Instituto de Medicina Tropical da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, SP 05403-000, Brazil. Electronic address: sabinoec@usp.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buss</LastName><ForeName>Lewis F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Departamento de Molestias Infecciosas e Parasitarias and Instituto de Medicina Tropical da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, SP 05403-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Maria P S</ForeName><Initials>MPS</Initials><AffiliationInfo><Affiliation>Funda&#xe7;&#xe3;o Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prete</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Departamento de Engenharia de Sistemas Eletr&#xf4;nicos, Escola Polit&#xe9;cnica da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crispim</LastName><ForeName>Myuki A E</ForeName><Initials>MAE</Initials><AffiliationInfo><Affiliation>Funda&#xe7;&#xe3;o Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraiji</LastName><ForeName>Nelson A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Funda&#xe7;&#xe3;o Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Rafael H M</ForeName><Initials>RHM</Initials><AffiliationInfo><Affiliation>Institute for Applied Economic Research-Ipea, Bras&#xed;lia, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parag</LastName><ForeName>Kris V</ForeName><Initials>KV</Initials><AffiliationInfo><Affiliation>MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva Peixoto</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Mathematics and Statistics, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraemer</LastName><ForeName>Moritz U G</ForeName><Initials>MUG</Initials><AffiliationInfo><Affiliation>Department of Zoology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oikawa</LastName><ForeName>Marcio K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Center of Mathematics, Computing and Cognition-Universidade Federal do ABC, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salomon</LastName><ForeName>Tassila</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Funda&#xe7;&#xe3;o Hemominas-Funda&#xe7;&#xe3;o Centro de Hematologia e Hemoterapia de Minas Gerais, Belo Horizonte, Brazil; Faculdade Ci&#xea;ncias M&#xe9;dicas de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cucunuba</LastName><ForeName>Zulma M</ForeName><Initials>ZM</Initials><AffiliationInfo><Affiliation>MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>M&#xe1;rcia C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza Santos</LastName><ForeName>Andreza Aruska</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Oxford School of Global and Area Studies, Latin American Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nascimento</LastName><ForeName>V&#xed;tor H</ForeName><Initials>VH</Initials><AffiliationInfo><Affiliation>Departamento de Engenharia de Sistemas Eletr&#xf4;nicos, Escola Polit&#xe9;cnica da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Henrique S</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Centro de Ci&#xea;ncias Ambientais, Universidade Federal do Amazonas, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferguson</LastName><ForeName>Neil M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pybus</LastName><ForeName>Oliver G</ForeName><Initials>OG</Initials><AffiliationInfo><Affiliation>Department of Zoology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kucharski</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busch</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Vitalant Research Institute, San Francisco, CA, USA; University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dye</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Zoology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faria</LastName><ForeName>Nuno R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Departamento de Molestias Infecciosas e Parasitarias and Instituto de Medicina Tropical da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, SP 05403-000, Brazil; MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, London, UK; Department of Zoology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>206250/Z/17/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R015600/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S019510/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R024855/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19012</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>30</Day><Hour>20</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33515491</ArticleId><ArticleId IdType="pmc">PMC7906746</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(21)00183-5</ArticleId><ArticleId IdType="pii">S0140-6736(21)00183-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lucy CO, Verity R, Watson OJ, et al. Have deaths from COVID-19 in Europe plateaued due to herd immunity? Lancet. 2020;395:e110&#x2013;e111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289569</ArticleId><ArticleId IdType="pubmed">32534627</ArticleId></ArticleIdList></Reference><Reference><Citation>Buss LF, Prete CA, Abrahim CMM, et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science. 2020;371:288&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857406</ArticleId><ArticleId IdType="pubmed">33293339</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez-Antonio C, Meza-S&#xe1;nchez G, Calampa C, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. MedRxiv. 2021 doi: 10.1101/2021.01.17.21249913. published online 20. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.17.21249913</ArticleId><ArticleId IdType="pmc">PMC8133769</ArticleId><ArticleId IdType="pubmed">34022148</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontanet A, Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020;20:583&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7480627</ArticleId><ArticleId IdType="pubmed">32908300</ArticleId></ArticleIdList></Reference><Reference><Citation>Funda&#xe7;&#xe3;o de Vigil&#xe2;ncia em Sa&#xfa;de do Amazonas  COVID-19 no Amazonas. Dados epidemiol&#xf3;gicos e financeiros das a&#xe7;&#xf5;es de combate &#xe0; COVID-19. Publica&#xe7;&#xf5;es. http://www.fvs.am.gov.br/publicacoes</Citation></Reference><Reference><Citation>Prefeitura de Manaus  Publica&#xe7;&#xf5;es. COVID-19. http://www.manaus.am.gov.br/noticia/</Citation></Reference><Reference><Citation>Funda&#xe7;&#xe3;o de Vigil&#xe2;ncia em Sa&#xfa;de do Amazonas  Index of media publicacao. http://www.fvs.am.gov.br/media/publicacao</Citation></Reference><Reference><Citation>Marcelo Oliveira capyvara  . GitHub; 2021. Popular repositories.https://github.com/capyvara</Citation></Reference><Reference><Citation>Nelson BW, Instituto Nacional de Pesquisas da Amaz&#xf4;nia (INPA)  Excess deaths Manaus. 2021. https://t.co/6g4HHEAuNY</Citation></Reference><Reference><Citation>Parag KV, Cowling BJ, Donnelly CA, et al. Deciphering early-warning signals of the elimination and resurgence potential of SARS-CoV-2 from limited data at multiple scales. MedRxiv. 2020 doi: 10.1101/2020.11.23.20236968. published online Jan 5. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.23.20236968</ArticleId><ArticleId IdType="pmc">PMC8672070</ArticleId><ArticleId IdType="pubmed">34905965</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassila S, Pybus O, Fran&#xe7;a R, et al. Coronavirus prevalence in Brazilian Amazon and Sao Paulo city [data set] Dryad. 2020 doi: 10.5061/dryad.c59zw3r5n. published online Dec 8.</Citation><ArticleIdList><ArticleId IdType="doi">10.5061/dryad.c59zw3r5n</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan JM, Mateu J, Kato Y, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021 doi: 10.1126/science.abf4063. published online Jan 6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4063</ArticleId><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumley SF, O'Donnell D, Stoesser NE, et al. Antibody status and incidence of SARS-CoV-2 infection in health care workers. N Engl J Med. 2020 doi: 10.1056/NEJMoa2034545. published online Dec 23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034545</ArticleId><ArticleId IdType="pmc">PMC7781098</ArticleId><ArticleId IdType="pubmed">33369366</ArticleId></ArticleIdList></Reference><Reference><Citation>ODS Atlas Amazonas  Inloco. &#xcd;ndice de Isolamento Social das cidades do Amazonas. Dados cedidos pela empresa Inloco. https://datastudio.google.com/s/o1rTqejYd_4</Citation></Reference><Reference><Citation>Greaney AJ, Loes AN, Crawford KHD, et al. Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies. BioRxiv. 2021 doi: 10.1101/2020.12.31.425021. published online Jan 4. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.31.425021</ArticleId><ArticleId IdType="pmc">PMC7869748</ArticleId><ArticleId IdType="pubmed">33592168</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria NR, Claro IM, Candido D, et al.  Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings. Virological. January, 2021. https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586</Citation></Reference><Reference><Citation>Rambaut A, Loman N, Pybus OG, et al.  Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological. December, 2020. https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563</Citation></Reference><Reference><Citation>Tegally H, Wilkinson E, Giovanetti M, et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. MedRxiv. 2020 doi: 10.1101/2020.12.21.20248640. published online Dec 22. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.21.20248640</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveca F, da Costa C, Nascimento V, et al.  SARS-CoV-2 reinfection by the new variant of concern (VOC) P.1 in Amazonas, Brazil. Virological. Jan 18, 2021. https://virological.org/t/sars-cov-2-reinfection-by-the-new-variant-of-concern-voc-p-1-in-amazonas-brazil/596</Citation></Reference><Reference><Citation>Naveca F, Nascimento V, Souza V, et al.  Phylogenetic relationship of SARS-CoV-2 sequences from Amazonas with emerging Brazilian variants harboring mutations E484K and N501Y in the Spike protein. Virological. Jan 11, 2021. https://virological.org/t/phylogenetic-relationship-of-sars-cov-2-sequences-from-amazonas-with-emerging-brazilian-variants-harboring-mutations-e484k-and-n501y-in-the-spike-protein/585</Citation></Reference><Reference><Citation>Nonaka VCK, Franco MM, Gr&#xe4;f T, et al. Genomic evidence of a SARS-Cov-2 reinfection case with E484K spike mutation in Brazil. Preprints. 2021 doi: 10.20944/preprints202101.0132.v1. published online Jan 6. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202101.0132.v1</ArticleId><ArticleId IdType="pmc">PMC8084516</ArticleId><ArticleId IdType="pubmed">33605869</ArticleId></ArticleIdList></Reference><Reference><Citation>Resende PC, Bezerra JF, Vasconcelos RHT, et al.  Spike E484K mutation in the first SARS-CoV-2 reinfection case confirmed in Brazil, 2020. Virological. Jan 10, 2021. https://virological.org/t/spike-e484k-mutation-in-the-first-sars-cov-2-reinfection-case-confirmed-in-brazil-2020/584</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>
